Pictet Asset Management Sa Travere Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 1,957,120 shares of TVTX stock, worth $36.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,957,120
Previous 1,550,502
26.22%
Holding current value
$36.6 Million
Previous $34.9 Million
13.79%
% of portfolio
0.04%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding TVTX
# of Institutions
194Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$143 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$143 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$129 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$87.6 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$81.2 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.2B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...